DK1663191T3 - Sammensætning omfattende rosiglitazon og metformin - Google Patents

Sammensætning omfattende rosiglitazon og metformin

Info

Publication number: DK1663191T3
Authority: DK; Denmark
Prior art keywords: rosiglitazone; metformin; composition
Prior art date: 2003-08-11

Application number

DK04741403.2T

Other languages

English (en)

Inventor

Peter John Coles

Paul Norman Mudd Jr

Donald Colin Mackenzie

Original Assignee

Smithkline Beecham Cork Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-08-11

Filing date

2004-08-09

Publication date

2010-04-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27840010&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1663191(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-08-09 Application filed by Smithkline Beecham Cork Ltd filed Critical Smithkline Beecham Cork Ltd

2010-04-26 Application granted granted Critical

2010-04-26 Publication of DK1663191T3 publication Critical patent/DK1663191T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Hematology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK04741403.2T 2003-08-11 2004-08-09 Sammensætning omfattende rosiglitazon og metformin DK1663191T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0318824.0A GB0318824D0 (en)	2003-08-11	2003-08-11	Novel composition
PCT/EP2004/008970 WO2005013956A1 (en)	2003-08-11	2004-08-09	Novel composition comprising rosiglitazone and another antidiabetic agent

Publications (1)

Publication Number	Publication Date
DK1663191T3 true DK1663191T3 (da)	2010-04-26

Family

ID=27840010

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK04741403.2T DK1663191T3 (da)	2003-08-11	2004-08-09	Sammensætning omfattende rosiglitazon og metformin

Country Status (36)

Country	Link
US (1)	US20080206336A1 (da)
EP (1)	EP1663191B1 (da)
JP (1)	JP4714147B2 (da)
KR (1)	KR20060071396A (da)
CN (2)	CN1835741B (da)
AP (1)	AP2006003489A0 (da)
AR (1)	AR045230A1 (da)
AT (1)	ATE455542T1 (da)
AU (1)	AU2004262933B2 (da)
BR (1)	BRPI0413419A (da)
CA (1)	CA2534480A1 (da)
CY (1)	CY1109923T1 (da)
DE (1)	DE602004025257D1 (da)
DK (1)	DK1663191T3 (da)
EA (2)	EA200800966A1 (da)
EC (1)	ECSP066338A (da)
ES (1)	ES2339554T3 (da)
GB (1)	GB0318824D0 (da)
HR (1)	HRP20100160T1 (da)
IL (1)	IL173177A0 (da)
IS (1)	IS2745B (da)
MA (1)	MA27996A1 (da)
MX (1)	MXPA06001629A (da)
MY (1)	MY151053A (da)
NO (1)	NO20061161L (da)
NZ (1)	NZ544632A (da)
OA (1)	OA13233A (da)
PE (1)	PE20050357A1 (da)
PL (1)	PL1663191T3 (da)
PT (1)	PT1663191E (da)
SG (1)	SG165178A1 (da)
SI (1)	SI1663191T1 (da)
TW (1)	TW200517146A (da)
UA (1)	UA82537C2 (da)
UY (1)	UY28461A1 (da)
WO (1)	WO2005013956A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY125516A (en) *	1999-11-16	2006-08-30	Smithkline Beecham Plc	Novel composition based on thiazolidinedione and metformin and use
GB0203296D0 (en) *	2002-02-12	2002-03-27	Glaxo Group Ltd	Novel composition
US8637512B2 (en)	2002-07-29	2014-01-28	Glaxo Group Limited	Formulations and method of treatment
JP2007512350A (ja) *	2003-11-25	2007-05-17	エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド	カルベジロール組成物の治療および送達方法
US20100323016A1 (en) *	2008-07-18	2010-12-23	Biljana Nadjsombati	Modified release formulation and methods of use
US20100323015A1 (en) *	2008-07-18	2010-12-23	Biljana Nadjsombati	Modified release formulation and methods of use
CA2731008A1 (en) *	2008-07-18	2010-01-21	Valeant Pharmaceuticals International	Modified release formulation and methods of use
WO2011161521A1 (en) *	2010-06-21	2011-12-29	Lupin Limited	Compositions comprising metformin and rosiglitazone
RU2016125229A (ru) *	2010-07-09	2018-12-04	БиЭйчВи ФАРМА, ИНК.	Комбинированная система доставки с немедленным/замедленным высвобождением для лекарственных средств с коротким периодом полувыведения, в том числе для ремоглифлозина
CN105663130B (zh) *	2011-04-15	2019-08-09	江苏豪森药业集团有限公司	一种具有第一和第二活性药物的制剂
CN118001246A (zh) *	2024-01-31	2024-05-10	四川鲁徽制药有限责任公司	一种达格列净、吡格列酮复方缓释片及其制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3845770A (en) *	1972-06-05	1974-11-05	Alza Corp	Osmatic dispensing device for releasing beneficial agent
GB8820353D0 (en) *	1988-08-26	1988-09-28	Staniforth J N	Controlled release tablet
US5952509A (en) *	1996-06-27	1999-09-14	Takeda Chemical Industries, Ltd.	Production of benzaldehyde compounds
GB9619757D0 (en) *	1996-09-21	1996-11-06	Knoll Ag	Chemical process
US20010049380A1 (en) *	1997-06-18	2001-12-06	Smith Stephen Alistair	Treatment of diabetes with thiazolidinedione and sulphonylurea
US20020004515A1 (en) *	1997-06-18	2002-01-10	Smith Stephen Alistair	Treatment of diabetes with thiazolidinedione and metformin
US20020006939A1 (en) *	1997-10-13	2002-01-17	Smithkline Beecham P.L.C.	Use of thiazolidinediones for the treatment of hyperglycaemia
AU3024399A (en) *	1998-04-03	1999-10-25	Bm Research A/S	Controlled release composition
US6099862A (en) *	1998-08-31	2000-08-08	Andrx Corporation	Oral dosage form for the controlled release of a biguanide and sulfonylurea
UA67802C2 (uk) *	1998-10-23	2004-07-15	Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А.	Фармацевтична композиція з контрольованим вивільненням інгібітора цгмф фде-5 (варіанти), спосіб її одержання та спосіб лікування еректильної дисфункції
DE69833179T2 (de) *	1998-11-10	2006-09-07	The Procter & Gamble Company, Cincinnati	Bleichmittelzusammensetzungen
US20030153607A1 (en) *	1998-11-12	2003-08-14	Smithkline Beecham P.L.C.	Novel composition and use
US20040102486A1 (en) *	1998-11-12	2004-05-27	Smithkline Beecham Corporation	Novel method of treatment
US20040081697A1 (en) *	1998-11-12	2004-04-29	Smithkline Beecham P.L.C.	Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
OA11677A (en) *	1998-11-12	2005-01-12	Smithkline Beecham Plc	Pharmaceutical composition for modified release ofan insulin sensitiser and another antidiabetic agent.
JP2003514011A (ja) *	1999-11-16	2003-04-15	スミスクラインビーチャムパブリックリミテッドカンパニー	チアゾリジンジオン−塩酸メトホルミンを含む医薬組成物
ES2290130T3 (es) *	2000-05-01	2008-02-16	Aeropharm Technology, Llc	Formulacion de nucleo.
GB0027471D0 (en) *	2000-11-08	2000-12-27	Smithkline Beecham Plc	Processes
GB0120835D0 (en) *	2001-08-28	2001-10-17	Smithkline Beecham Plc	Process
GB0127805D0 (en) *	2001-11-20	2002-01-09	Smithkline Beecham Plc	Pharmaceutical composition
PE20030800A1 (es) *	2002-02-12	2003-10-31	Glaxo Group Ltd	Forma de dosificacion oral de liberacion controlada
GB0203296D0 (en) *	2002-02-12	2002-03-27	Glaxo Group Ltd	Novel composition
US7785627B2 (en) *	2002-09-20	2010-08-31	Watson Pharmaceuticals, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

2003
- 2003-08-11 GB GBGB0318824.0A patent/GB0318824D0/en not_active Ceased
2004
- 2004-08-09 OA OA1200600045A patent/OA13233A/en unknown
- 2004-08-09 CN CN2004800232304A patent/CN1835741B/zh not_active Expired - Fee Related
- 2004-08-09 JP JP2006522974A patent/JP4714147B2/ja not_active Expired - Fee Related
- 2004-08-09 AR ARP040102846A patent/AR045230A1/es not_active Application Discontinuation
- 2004-08-09 SI SI200431376T patent/SI1663191T1/sl unknown
- 2004-08-09 EA EA200800966A patent/EA200800966A1/ru unknown
- 2004-08-09 AU AU2004262933A patent/AU2004262933B2/en not_active Ceased
- 2004-08-09 AP AP2006003489A patent/AP2006003489A0/xx unknown
- 2004-08-09 CA CA002534480A patent/CA2534480A1/en not_active Abandoned
- 2004-08-09 PL PL04741403T patent/PL1663191T3/pl unknown
- 2004-08-09 US US10/567,803 patent/US20080206336A1/en not_active Abandoned
- 2004-08-09 ES ES04741403T patent/ES2339554T3/es not_active Expired - Lifetime
- 2004-08-09 SG SG200901679-1A patent/SG165178A1/en unknown
- 2004-08-09 KR KR1020067002884A patent/KR20060071396A/ko not_active Ceased
- 2004-08-09 WO PCT/EP2004/008970 patent/WO2005013956A1/en not_active Ceased
- 2004-08-09 EP EP04741403A patent/EP1663191B1/en not_active Expired - Lifetime
- 2004-08-09 HR HR20100160T patent/HRP20100160T1/hr unknown
- 2004-08-09 TW TW093123804A patent/TW200517146A/zh unknown
- 2004-08-09 CN CN2011103143770A patent/CN102397551A/zh active Pending
- 2004-08-09 DK DK04741403.2T patent/DK1663191T3/da active
- 2004-08-09 MX MXPA06001629A patent/MXPA06001629A/es active IP Right Grant
- 2004-08-09 DE DE602004025257T patent/DE602004025257D1/de not_active Expired - Lifetime
- 2004-08-09 PE PE2004000771A patent/PE20050357A1/es not_active Application Discontinuation
- 2004-08-09 PT PT04741403T patent/PT1663191E/pt unknown
- 2004-08-09 UY UY28461A patent/UY28461A1/es not_active Application Discontinuation
- 2004-08-09 EA EA200600400A patent/EA011550B1/ru not_active IP Right Cessation
- 2004-08-09 AT AT04741403T patent/ATE455542T1/de active
- 2004-08-09 NZ NZ544632A patent/NZ544632A/en not_active IP Right Cessation
- 2004-08-09 BR BRPI0413419-2A patent/BRPI0413419A/pt not_active IP Right Cessation
- 2004-08-09 MY MYPI20043234 patent/MY151053A/en unknown
- 2004-09-08 UA UAA200601353A patent/UA82537C2/uk unknown
2006
- 2006-01-16 IL IL173177A patent/IL173177A0/en unknown
- 2006-01-31 EC EC2006006338A patent/ECSP066338A/es unknown
- 2006-02-17 MA MA28817A patent/MA27996A1/fr unknown
- 2006-03-02 IS IS8337A patent/IS2745B/is unknown
- 2006-03-10 NO NO20061161A patent/NO20061161L/no not_active Application Discontinuation
2010
- 2010-03-22 CY CY20101100261T patent/CY1109923T1/el unknown

Also Published As

Publication number	Publication date
GB0318824D0 (en)	2003-09-10
HRP20100160T1 (hr)	2010-05-31
EA011550B1 (ru)	2009-04-28
EP1663191A1 (en)	2006-06-07
CN1835741B (zh)	2011-12-14
IS8337A (is)	2006-03-02
UA82537C2 (uk)	2008-04-25
IS2745B (is)	2011-08-15
EA200600400A1 (ru)	2006-08-25
BRPI0413419A (pt)	2006-10-10
MA27996A1 (fr)	2006-07-03
EP1663191B1 (en)	2010-01-20
SI1663191T1 (sl)	2010-05-31
MY151053A (en)	2014-03-31
NZ544632A (en)	2009-03-31
US20080206336A1 (en)	2008-08-28
CY1109923T1 (el)	2014-09-10
NO20061161L (no)	2006-03-10
HK1092051A1 (en)	2007-02-02
CN1835741A (zh)	2006-09-20
PE20050357A1 (es)	2005-06-01
AU2004262933A1 (en)	2005-02-17
CA2534480A1 (en)	2005-02-17
MXPA06001629A (es)	2006-04-28
JP4714147B2 (ja)	2011-06-29
WO2005013956A1 (en)	2005-02-17
EA200800966A1 (ru)	2009-04-28
IL173177A0 (en)	2006-06-11
CN102397551A (zh)	2012-04-04
AP2006003489A0 (en)	2006-02-28
TW200517146A (en)	2005-06-01
ECSP066338A (es)	2006-07-28
UY28461A1 (es)	2005-03-31
DE602004025257D1 (de)	2010-03-11
JP2007501830A (ja)	2007-02-01
AR045230A1 (es)	2005-10-19
PT1663191E (pt)	2010-03-16
AU2004262933B2 (en)	2009-12-10
OA13233A (en)	2006-12-13
ES2339554T3 (es)	2010-05-21
ATE455542T1 (de)	2010-02-15
SG165178A1 (en)	2010-10-28
PL1663191T3 (pl)	2010-06-30
KR20060071396A (ko)	2006-06-26

Publication	Publication Date	Title
NO20053974D0 (no)	2005-08-25	Tienopyrimidinforbindelser og anvendelse derav.
DK1948149T3 (da)	2012-02-20	Præparat indeholdende metformin og vildagliptin
DE502004002833D1 (de)	2007-03-22	Alkoxysilanterminierte prepolymere
NL1025404A1 (nl)	2004-08-09	Pyrazolo-triazine verbindingen en gebruik daarvan.
DK1480955T3 (da)	2007-10-29	O-cyclopropyl-carboxanilider og deres anvendelse som fungicider
NO20055837D0 (no)	2005-12-08	Immunsupprimerende forbindelser og sammensetninger
DE10393374D2 (de)	2005-09-01	Zusammensetzung
NO2016020I1 (no)	2016-10-20	Imidacloprid og Flumetrin
DK1675852T3 (da)	2009-05-25	Heterocykliske 7-amino-alkylidenyl-quinoloner og -naphthyridoner
DK1601744T3 (da)	2012-08-20	Forgasningsapparat og fremgangsmåde
DE602004018936D1 (de)	2009-02-26	Härtbare zusammensetzung
DK1663191T3 (da)	2010-04-26	Sammensætning omfattende rosiglitazon og metformin
SE0500163L (sv)	2005-01-24	Sammansättning
DK1814977T3 (da)	2014-09-29	Arthrospira-baserede sammensætninger og anvendelser deraf
DK1829874T3 (da)	2014-05-12	Tricyklisk forbindelse og anvendelse deraf
SE0302495L (sv)	2005-03-20	Transportkomposition
DK1572950T3 (da)	2013-02-04	Enkeltdomæne TDF-relaterede forbindelser og analoger deraf
IS7783A (is)	2005-04-01	Flóð og fjöru-ker
IS8344A (is)	2006-03-09	Útskipt þíófen og notkun þeirra
IS8489A (is)	2006-05-26	Umritunarstillar og aðferðir þeirra
EP1561467A4 (en)	2008-06-25	COMPOSITION FOR RECOVERING DAMAGED SKIN
DK1680134T3 (da)	2014-07-14	Sammensætninger og anvendelser deraf
NO20055582D0 (no)	2005-11-25	Preparater og fremgangsmater omfattende gastrinforbindelser
DE602004032031D1 (de)	2011-05-12	Spielfreie c-ring-anordnung
SE0302396L (sv)	2005-03-09	A novel deicing composition and use thereof